Oaxaca, D. M., Yang-Reid, S. A., Ross, J. A., Rodriguez, G., Staniswalis, J. G., & Kirken, R. A. (2016). Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumour Biol.
Chicago Stili AlıntıOaxaca, Derrick M., Sun Ah Yang-Reid, Jeremy A. Ross, Georgialina Rodriguez, Joan G. Staniswalis, ve Robert A. Kirken. "Sensitivity of Imatinib-resistant T315I BCR-ABL CML to a Synergistic Combination of Ponatinib and Forskolin Treatment." Tumour Biol 2016.
MLA AlıntıOaxaca, Derrick M., et al. "Sensitivity of Imatinib-resistant T315I BCR-ABL CML to a Synergistic Combination of Ponatinib and Forskolin Treatment." Tumour Biol 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..